Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy

Avaí Bio and Austrianova announced completion of a GMP Master Cell Bank containing genetically modified cells that overexpress the α-Klotho protein. The MCB will undergo comprehensive viral and contamination testing to meet FDA regulatory standards. Upon successful completion, the companies will generate a Working Cell Bank to manufacture the final Cell-in-a-Box encapsulated clinical product for treating age-related disorders.